JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2005; 46:582-588, doi:10.1016/j.jacc.2004.12.081 (Published online 27 July 2005).
© 2005 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow View Online Only Appendix
Right arrow All Versions of this Article:
j.jacc.2004.12.081v1
46/4/582    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JACC
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (24)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rodriguez, A. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rodriguez, A. E.

CLINICAL RESEARCH: CLINICAL TRIALS

Five-Year Follow-Up of the Argentine Randomized Trial of Coronary Angioplasty With Stenting Versus Coronary Bypass Surgery in Patients With Multiple Vessel Disease (ERACI II)

Alfredo E. Rodriguez, MD, PhD, FACC*, Julio Baldi, MD, PhD*, Carlos Fernández Pereira, MD*, Jose Navia, MD*, Máximo Rodriguez Alemparte, MD*, Alejandro Delacasa, MD{dagger}, Federico Vigo, MD*, Daniel Vogel, MD*, William O'Neill, MD, FACC{ddagger}, Igor F. Palacios, MD, FACC,§,* on behalf of the ERACI II Investigators

* Otamendi Hospital, Buenos Aires, Argentina
{dagger} Sanatorio Belgrano, Mar del Plata, Argentina
{ddagger} William Beaumont Hospital, Royal Oak, Michigan
§ Massachusetts General Hospital, Boston, Massachusetts

Manuscript received October 11, 2004; revised manuscript received December 13, 2004, accepted December 20, 2004.

* Reprint requests and correspondence: Dr. Igor F. Palacios, Cardiac Catheterization Laboratory, Interventional Cardiology, Massachusetts General Hospital, Boston, Massachusetts 02114 (Email: ipalacios{at}partners.org).

OBJECTIVES: The purpose of the present study is to report the five-year follow-up results of the ERACI II trial.

BACKGROUND: Immediate and one-year follow-up results of the ERACI II study showed a prognosis advantage of percutaneous coronary intervention (PCI) with stents over coronary artery bypass grafting (CABG).

METHODS: A total of 450 patients were randomly assigned to undergo either PCI (n = 225); or CABG (n = 225). Only patients with multi-vessel disease were enrolled. Clinical follow-up during five years was obtained in 92% of the total population after hospital discharge. The primary end point of the study was to compare freedom from major adverse cardiovascular events (MACE) at 30 days, 1 year, 3 years, and 5 years of follow-up.

RESULTS: At five years of follow-up, patients initially treated with PCI had similar survival and freedom from non-fatal acute myocardial infarction than those initially treated with CABG (92.8% vs. 88.4% and 97.3% vs. 94% respectively, p = 0.16). Freedom from repeat revascularization procedures (PCI/CABG) was significantly lower with PCI compared with CABG (71.5% vs. 92.4%, p = 0.0002). Freedom from MACE was also significantly lower with PCI compared with CABG (65.3% vs. 76.4%; p = 0.013). At five years similar numbers of patients randomized to each revascularization procedure were asymptomatic or with class I angina.

CONCLUSIONS: At five years of follow-up, in the ERACI II study, there were no survival benefits from any revascularization procedure; however patients initially treated with CABG had better freedom from repeat revascularization procedures and from MACE.

Abbreviations and Acronyms
  AMI = acute myocardial infarction
  ARTS = Artery Revascularization Therapies Study
  CABG = coronary artery bypass grafting
  CAD = coronary artery disease
  ERACI II = Argentine Randomized Study: Coronary Angioplasty with Stenting Versus Coronary Bypass Surgery in Multi-Vessel Disease
  LAD = left anterior descending
  LIMA = left internal mammary artery graft
  MACE = major adverse cardiovascular events
  PCI = percutaneous coronary intervention
  PTCA = percutaneous transluminal coronary angioplasty


Related articles in JACC:

Stenting or Surgery: An Opportunity to Do it Right
Robert M. Califf
JACC 2005 46: 589-591. [Full Text]  



This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
H.-C. Lin, S. Xirasagar, N.-W. Tsao, Y.-T. Hwang, N.-W. Kuo, and H.-C. Lee
Volume-outcome relationships in coronary artery bypass graft surgery patients: 5-year major cardiovascular event outcomes.
J. Thorac. Cardiovasc. Surg., April 1, 2008; 135(4): 923 - 930.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. Brinker
The left main facts: faced, spun, but alas too few.
J. Am. Coll. Cardiol., March 4, 2008; 51(9): 893 - 898.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
C. Rao, R. D. L. Stanbridge, J. Chikwe, J. Pepper, P. Skapinakis, O. Aziz, A. Darzi, and T. Athanasiou
Does Previous Percutaneous Coronary Stenting Compromise the Long-Term Efficacy of Subsequent Coronary Artery Bypass Surgery? A Microsimulation Study
Ann. Thorac. Surg., February 1, 2008; 85(2): 501 - 507.
[Abstract] [Full Text] [PDF]


Home page
Card Surg AdultHome page
I. George and M. C. Oz
Myocardial Revascularization after Acute Myocardial Infarction
Card. Surg. Adult, January 1, 2008; 3(2008): 669 - 696.
[Full Text]


Home page
ANN INTERN MEDHome page
D. M. Bravata, A. L. Gienger, K. M. McDonald, V. Sundaram, M. V. Perez, R. Varghese, J. R. Kapoor, R. Ardehali, D. K. Owens, and M. A. Hlatky
Systematic Review: The Comparative Effectiveness of Percutaneous Coronary Interventions and Coronary Artery Bypass Graft Surgery
Ann Intern Med, November 20, 2007; 147(10): 703 - 716.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
T. Gershlick and M. Thomas
PCI or CABG: which patients and at what cost?
Heart, October 1, 2007; 93(10): 1188 - 1190.
[Full Text] [PDF]


Home page
CirculationHome page
T. L. Bair, J. B. Muhlestein, H. T. May, K. G. Meredith, B. D. Horne, R. R. Pearson, Q. Li, K. R. Jensen, J. L. Anderson, and D. L. Lappe
Surgical Revascularization Is Associated With Improved Long-Term Outcomes Compared With Percutaneous Stenting in Most Subgroups of Patients With Multivessel Coronary Artery Disease: Results From the Intermountain Heart Registry
Circulation, September 11, 2007; 116(11_suppl): I-226 - I-231.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Thielmann, M. Neuhauser, S. Knipp, E. Kottenberg-Assenmacher, A. Marr, N. Pizanis, M. Hartmann, M. Kamler, P. Massoudy, and H. Jakob
Prognostic impact of previous percutaneous coronary intervention in patients with diabetes mellitus and triple-vessel disease undergoing coronary artery bypass surgery
J. Thorac. Cardiovasc. Surg., August 1, 2007; 134(2): 470 - 476.
[Abstract] [Full Text] [PDF]


Home page
Asian Cardiovasc. Thorac. Ann.Home page
S. H Wong, S. Wan, and M. J Underwood
Myocardial Revascularization: Surgery or Stenting?
Asian Cardiovasc Thorac Ann, June 1, 2007; 15(3): 264 - 269.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. Berry, J.-C. Tardif, and M. G. Bourassa
Coronary Heart Disease in Patients With Diabetes: Part II: Recent Advances in Coronary Revascularization
J. Am. Coll. Cardiol., February 13, 2007; 49(6): 643 - 656.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
V. J. Dzau, E. M. Antman, H. R. Black, D. L. Hayes, J. E. Manson, J. Plutzky, J. J. Popma, and W. Stevenson
The Cardiovascular Disease Continuum Validated: Clinical Evidence of Improved Patient Outcomes: Part I: Pathophysiology and Clinical Trial Evidence (Risk Factors Through Stable Coronary Artery Disease)
Circulation, December 19, 2006; 114(25): 2850 - 2870.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
P. K. Smith, R. M. Califf, R. H. Tuttle, L. K. Shaw, K. L. Lee, E. R. Delong, R. E. Lilly, M. H. Sketch Jr, E. D. Peterson, and R. H. Jones
Selection of surgical or percutaneous coronary intervention provides differential longevity benefit.
Ann. Thorac. Surg., October 1, 2006; 82(4): 1420 - 1429.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. T. Stroupe, D. A. Morrison, M. A. Hlatky, P. G. Barnett, L. Cao, C. Lyttle, D. M. Hynes, W. G. Henderson, and for the Investigators of Veterans Affairs Cooperat
Cost-Effectiveness of Coronary Artery Bypass Grafts Versus Percutaneous Coronary Intervention for Revascularization of High-Risk Patients
Circulation, September 19, 2006; 114(12): 1251 - 1257.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
R. A. Guyton
Coronary Artery Bypass is Superior to Drug-Eluting Stents in Multivessel Coronary Artery Disease
Ann. Thorac. Surg., June 1, 2006; 81(6): 1949 - 1957.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. R. Dixon, C. L. Grines, and W. W. O'Neill
The Year in Interventional Cardiology
J. Am. Coll. Cardiol., April 18, 2006; 47(8): 1689 - 1706.
[Full Text] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2005 by the American College of Cardiology Foundation.